Table 2 Outcomes of patients with cancer and without cancer before and after propensity score matched analysis
Outcome | ALL | Patients before PSM | Patients after PSM | ||||
|---|---|---|---|---|---|---|---|
n = 38,508 | Noncancer N = 30,200 | Cancer N = 8308 | P Value | Noncancer N = 7474 | Cancer N = 7474 | P Value | |
LOS of ICU, median (IQR), d | 2.1 (1.2–4.1) | 2.1 (1.2–4.1) | 2.1 (1.2–3.9) | < 0.001 | 2.1 (1.2–4.2) | 2.1 (1.2–3.9) | < 0.001 |
LOS of Hospital, median (IQR), d | 6.9 (4.0–11.9) | 6.8 (4.0–11.8) | 7.3 (4.4–12.2) | < 0.001 | 7.1 (4.2–12.6) | 7.2 (4.3–11.9) | 0.774 |
28-day survive, % (95%CI) | 86.6 (86.2–86.9) | 88.0 (87.6–88.4) | 81.3 (80.5–82.1) | < 0.001 | 84.9 (84.0–85.7) | 82.3 (81.4–83.1) | < 0.001 |
90-day survive, % (95%CI) | 81.8 (81.4–82.2) | 84.3 (83.9–84.7) | 72.9 (72.0–73.9) | < 0.001 | 79.2 (78.3–80.1) | 74.3 (73.3–75.3) | < 0.001 |
365-day survive, % (95%CI) | 74.9 (74.4–75.3) | 79.1 (78.7–79.6) | 59.3 (58.2–60.3) | < 0.001 | 72.7 (71.7–73.7) | 61.4 (60.3–62.5) | < 0.001 |
1095-day survive, % (95%CI) | 67.3 (66.9–67.8) | 72.6 (72.1–73.1) | 48.3 (47.3–49.4) | < 0.001 | 64.6 (63.5–65.7) | 50.4 (49.3–51.6) | < 0.001 |